Skip To Main Content
Denne hjemmeside er forbeholdt sundhedspersoner, der bor og/eller arbejder i Danmark
Campus
  • Uddannelse
  • Artikel
  • Reumatologi
  • Materiale
  • Vacciner
Campus
  • Uddannelse
  • Artikel
  • Reumatologi
  • Materiale
  • Vacciner
View Full Results

Artikel

Sorter efter

Filtre

Nulstil
  • Terapiområde
What is TTP? A rare, life-threatening medical emergency

What is TTP? A rare, life-threatening medical emergency

Early diagnosis and treatment of Thrombotic thrombocytopenic purpura (TTP) can help prevent the high risk of early deaths.

Læs mere
When to suspect TTP?

When to suspect TTP?

TTP is rare and presents similarly to other thrombotic microangiopathies (TMAs), making it difficult to diagnose.

Læs mere
How Does Glycaemic Control Impact Complications in Type 2 Diabetes?

How Does Glycaemic Control Impact Complications in Type 2 Diabetes?

Summary of The UK Prospective Diabetes Study (UKPDS).

Læs mere
Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?

Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?

Summary of Aschner P, et al. Diabetologia. 2020;63(4):711-721.

Læs mere
Is Glycemic Control the Key to Preventing Long-term Complications in Type 2 Diabetes?

Is Glycemic Control the Key to Preventing Long-term Complications in Type 2 Diabetes?

(Based on the study: Stratton IM, et al. BMJ. 2000;321(7258):405-12).

Læs mere
The Complex Burden of Autoimmune Type 1 Diabetes

The Complex Burden of Autoimmune Type 1 Diabetes

Læs mere
Betydningen af eksacerbationer ved KOL

Betydningen af eksacerbationer ved KOL

Læs mere
Betydningen af type 2-inflammation*

Betydningen af type 2-inflammation

Læs mere
Livskvalitet og vurdering af symptomer hos KOL-patienter

Livskvalitet og vurdering af symptomer hos KOL-patienter

Læs mere
Reflekter over ny tilgang til KOL

Reflekter over ny tilgang til KOL

At få en forståelse for type 2 inflammation* kan belyse hvorfor nogle KOL-patienter fortsætter med at få eksacerbationer. Se denne video og lær mere.1

Læs mere
Uncovering the Hidden Burden: Understanding Loss of Smell in CRSwNP

Uncovering the Hidden Burden: Understanding Loss of Smell in CRSwNP

Navigating the Complexities of Smell Loss in Patients with CRSwNP.

Læs mere
Long-Term Efficacy and Safety of Dupixent in Moderate-to-Severe Atopic Dermatitis: 5-Year Open-Label Extension Study Results<sup>1</sup>

LIBERTY studieprogram på atopisk eksem

Atopic dermatitis (AD) is a chronic inflammatory skin condition that can significantly impact patients' quality of life. Dupixent (dupilumab) has emerged as a treatment for moderate-to-severe AD. This article summarizes the findings of a 5-year open-label extension study (Beck et al, 2024), providing insights into the long-term efficacy and safety profile of Dupixent for dermatologists managing patients with persistent AD.

Læs mere